Profile

	DHR-PB	TMO	DHR	IDXX	A	IQV
Company Name	Danaher Corporation	Thermo Fisher Scientific Inc.	Danaher Corporation	IDEXX Laboratories, Inc.	Agilent Technologies, Inc.	IQVIA Holdings Inc.
Sector	Healthcare	Healthcare	Healthcare	Healthcare	Healthcare	Healthcare
Industry	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research
Market Cap	$916.76B	$203.95B	$153.12B	$51.47B	$36.74B	$31.93B
Employees	79.00K	125.00K	61.00K	11.00K	17.90K	89.00K
CEO	Rainer M. Blair	Marc N. Casper	Rainer Blair	Jonathan J. Mazelsky	Padraig McDonnell	Ari Bousbib

Ratings

	DHR-PB	TMO	DHR	IDXX	A	IQV
Quant Rating Score	5	3	3	3	3	3
Quant Rating	Strong Buy	Neutral	Neutral	Neutral	Neutral	Neutral

Trading

	DHR-PB	TMO	DHR	IDXX	A	IQV
Last Close	$1261.26	$567.16	$220.44	$669	$144.52	$216.12
High 52	$1261.26	$606.74	$250.59	$722.94	$152.6	$223.55
Low 52	$1261.26	$390.2	$174.64	$361.04	$99.29	$137
Price vs. 52 Week High	0 %	-6.52 %	-12.03 %	-7.46 %	-5.29 %	-3.32 %
Price vs. 52 Week Low	0 %	45.35 %	26.23 %	85.3 %	45.55 %	57.75 %

Total Return

	TMO	DHR	IDXX	A	IQV
1 Month Return	5.24 %	5.44 %	5.29 %	1.83 %	5.66 %
3 Month Return	16.29 %	5.47 %	4.88 %	22.32 %	12.25 %
6 Month Return	37.64 %	12.41 %	29.13 %	27.03 %	51.32 %
9 Month Return	8.42 %	7.78 %	48.98 %	6.89 %	11.89 %
YTD Return	9.02 %	-3.97 %	61.81 %	7.58 %	9.98 %
1 Year Return	11.4 %	-4.51 %	60.69 %	14.98 %	12.96 %
3 Year Return	0 %	0 %	0 %	0 %	0 %
5 Year Return	0 %	0 %	0 %	0 %	0 %

Dividends

	DHR-PB	TMO	DHR	IDXX	A	IQV
Dividend Yield Percentage (TTM)	0.59 %	0.32 %	0.59 %	-	0.77 %	-
Dividend Paid and Capex Coverage Ration (TTM)	3.15 %	3.62 %	3.15 %	9.48 %	2.26 %	15.25 %
Dividend Per Share (TTM)	1.28 %	1.72 %	1.28 %	-	1 %	-
Payout Ratio (TTM)	24.29 %	9.47 %	24.29 %	-	21.64 %	-

Growth

	DHR-PB	TMO	DHR	IDXX
Asset Growth	7.64 %	13.38 %	7.64 %	1.03 %
Gross Profit Growth	5.38 %	-5.36 %	5.38 %	8.63 %
Revenue Growth	2.9 %	3.91 %	2.9 %	6.46 %
Revenue 3 Year	-5.47 %	3.42 %	-5.47 %	25.23 %
Revenue 5 Year	10.08 %	45.65 %	10.08 %	69.09 %
Revenue 10 Year	68 %	178.48 %	68 %	218.38 %
EBIT Growth	-7.15 %	-6.71 %	-7.15 %	3.47 %
Net Income Growth	-7.31 %	6.35 %	-7.31 %	5.07 %
Net Income 3 Yeari Growth Per Share	-48.61 %	1.06 %	-48.61 %	23.15 %
Net Income 5 Yeari Growth Per Share	-1.03 %	11.3 %	-1.03 %	116.76 %
Net Income 10 Yeari Growth Per Share	37.36 %	261.63 %	37.36 %	492.42 %
Operating Income Growth	-0.91 %	5.83 %	-0.91 %	2.84 %
Operating Cash Flow Growth (CFG)	-4.07 %	-9.8 %	-4.07 %	2.48 %
Operating 3 Year CFG	-22.79 %	-10.96 %	-22.79 %	27.03 %
Operating 5 Year CFG	3.19 %	-0.67 %	3.19 %	111.28 %
Operating 10 Year CFG	66.57 %	194.29 %	66.57 %	378.1 %
EPS Growth	-4.88 %	7.18 %	-4.88 %	5.9 %
EPS Diluted Growth	-4.73 %	7.32 %	-4.73 %	6.06 %
Book Value Per Share	9.57 %	9.5 %	9.57 %	8.24 %
Share Holder 3 Year Equity Growth Per Share	7.54 %	26.63 %	7.54 %	138.87 %
Share Holder 5 Year Equity Growth Per Share	31.9 %	63.03 %	31.9 %	838.67 %
Share Holder 10 Year Equity Growth Per Share	118.87 %	165.29 %	118.87 %	1547.69 %
Dividend Per Share Growth	18.15 %	10.83 %	18.15 %	-
Dividend 3 Year Growth Per Share	10.04 %	45.73 %	10.04 %	-
Dividend 5 Year Growth Per Share	42.54 %	98.76 %	42.54 %	-
Dividend 10 Year Growth Per Share	144.73 %	180.3 %	144.73 %	-
Debt Growth	7.42 %	20.17 %	7.42 %	-7.53 %
Free Cash Flow Growth	-0.68 %	-13.4 %	-0.68 %	3.26 %
Updated On	31 Dec 2025	31 Dec 2025	31 Dec 2025	31 Dec 2024

Profitability

	DHR-PB	TMO	DHR	IDXX	A	IQV
Gross Profit Margin TTM	60.93 %	39.46 %	60.93 %	61.8 %	52.43 %	26.28 %
Return on Assets TTM	4.33 %	6.09 %	4.33 %	31.62 %	10.24 %	4.54 %
Return on Equity TTM	6.99 %	13.14 %	6.99 %	69.78 %	20.62 %	22.28 %
Return on Capital Employed TTM	6.7 %	8.41 %	6.7 %	61.76 %	14.25 %	10.59 %
Net Income Per EBT TTM	85.38 %	92.39 %	85.38 %	80.01 %	90.8 %	84.31 %
EBT Per Ebit TTM	82.4 %	90.83 %	82.4 %	97.36 %	97.03 %	70.53 %
EBIT Per Revenue TTM	20.91 %	17.96 %	20.91 %	31.6 %	21.29 %	14.02 %
Cash Flow To Debt Ratio TTM	34.84 %	19.85 %	34.84 %	1575.85 %	46.48 %	16.41 %
Receivables Turnover TTM	6.28	5.01	6.28	7.79	4.67	4.76
Payables Turnover TTM	5.2	-	5.2	14.89	5.8	3.21
Inventory Turnover TTM	3.86	4.97	3.86	4.35	3.22	-
Fixed Asset Turnover TTM	444.19 %	421.73 %	444.19 %	575.84 %	343.45 %	1981.77 %
Asset Turnover TTM	29.44 %	40.38 %	29.44 %	128.44 %	54.59 %	54.47 %
Operating Cash Flow Per Share TTM	9.07	20.79	9.07	14.75	5.51	15.61
Free Cash Flow Per Share TTM	7.44	16.74	7.44	13.2	4.07	14.59
Cash Per Share TTM	652.48 %	2687.5 %	652.48 %	224.82 %	632.16 %	1259.41 %
Operating Cash Flow Sales Ratio TTM	26.12 %	17.55 %	26.12 %	27.46 %	22.44 %	16.27 %
Free Cash Flow Operating Cash Flow Ratio TTM	81.98 %	80.49 %	81.98 %	89.45 %	73.89 %	93.44 %
Cash Flow Coverage Ratios TTM	34.84 %	19.85 %	34.84 %	1575.85 %	46.48 %	16.41 %
Price To Free Cash Flows Ratio TTM	29.11	32.41	29.11	48.69	31.89	12.87
Price To Operating Cash Flows Ratio TTM	23.88	26.11	23.88	43.69	23.52	12.01
Price Cash Flow Ratio TTM	23.88	26.11	23.88	43.69	23.52	12.01

Income Statement (TTM)

	DHR-PB	TMO	DHR	IDXX	A	IQV
Revenue	$24.57B	$44.56B	$24.57B	$4.3B	$6.95B	$16.31B
Gross Profit	$14.97B	$16.78B	$14.97B	$2.66B	$3.64B	$4.29B
Gross Profit Ratio	60.93%	37.66%	60.93%	61.8%	52.43%	26.28%
EBITDA	$6.95B	$10.89B	$6.95B	$1.47B	$1.84B	$3.46B
Net Income	$3.61B	$6.74B	$3.61B	$1.06B	$1.3B	$1.36B
EPS Diluted	5.04	17.74	5.04	13.08	4.57	7.84

Balance Sheet (MRQ)

	DHR-PB	TMO	DHR	IDXX	A	IQV
Long Term Debt	$18.42B	$35.85B	$18.42B	$0.37B	$3.05B	$14.33B
Total Liabilities	$30.93B	$56.81B	$30.93B	$1.75B	$5.99B	$23.31B
Total Equity	$52.54B	$53.54B	$52.54B	$1.61B	$6.74B	$6.63B
Total Investments	$0B	$0.25B	$0B	$0B	$0.13B	$0.59B
Total Debt	$18.42B	$39.39B	$18.42B	$0.85B	$3.35B	$16.17B
Total Assets	$83.46B	$110.34B	$83.46B	$3.35B	$12.73B	$29.94B

Cash Flow Statement (TTM)

	DHR-PB	TMO	DHR	IDXX	A	IQV
Net Income	$3.61B	$6.72B	$3.61B	$1.06B	$0.43B	$1.36B
Inventory	$-0.06B	$0B	$-0.06B	$0B	$0.05B	$0B
Dividends Paid	$-0.88B	$-0.64B	$-0.88B	$0B	$-0.28B	$0B
Operating Cash Flow	$6.42B	$7.82B	$6.42B	$1.18B	$1.56B	$2.65B
Capital Expenditure	$-1.16B	$-1.53B	$-1.16B	$-0.12B	$-0.41B	$-0.6B

Related Stocks

Ticker	Name	Price
A	Agilent Technologies, Inc.	129.58
ACRS	Aclaris Therapeutics, Inc.	3.57
ADVB	Advanced Biomed Inc. Common Stock	0.2319
AKU	Akumin Inc.	0.2887
APDN	Applied DNA Sciences, Inc.	5.62
AWH	Aspira Women's Health Inc.	0.082
BDSX	Biodesix, Inc.	10.38
BIAF	bioAffinity Technologies, Inc.	0.8512
BIAFW	bioAffinity Technologies, Inc.	0.2204
BIOC	Biocept, Inc.	0.4349
BLLN	BillionToOne, Inc.	90.61
BNGO	Bionano Genomics, Inc.	1.15
BNGOW	BioNano Genomics, Inc. WT EXP 082123	0.0036
BNR	Burning Rock Biotech Limited	34
CDNA	CareDx, Inc	19.47
CEMI	Chembio Diagnostics, Inc.	0.455
CHEK	Check-Cap Ltd.	1.68
CNTG	Centogene N.V.	0.325
CO	Global Cord Blood Corporation	2.9876
CRL	Charles River Laboratories International, Inc.	189.21

Unlock

Fidelitey